… anti tumor activity of Nos and to evaluate mechanisms and efficacy against NSCLC cells. The
H460 xenograft model was used to study in vivo anti tumor activity … Nos anti-tumor activity. …

… Linear mixed‐effects modeling was applied in the implementation of the estimation. We …
xenograft study of a new antitumor agent, temozolomide, combined with irinotecan. The model …

… human gastric cancer xenograft models We investigated the antitumor activity of trastuzumab
against NCI-N87 and 4-1ST xenograft models. Trastuzumab demonstrated significant …

… xenografts demonstrated that bruceantin induced regression in early as well as advanced
tumors, and these significant antitumor … cells in culture and xenograft models. Responses of …

… a potent activity against FGF/FGFR-mediated signaling in several cancer cell lines and
shows an excellent broad spectrum of antitumor activity in several tumor xenograft models …

… breast (KPL-4) xenograft tumors. The combination treatment … antitumor activity in both Calu-3
and KPL-4 xenograft models, … enhanced antitumor activity in KPL-4 and Calu-3 xenograft …

… In conclusion, in NSCLC, the antitumor activity of erlotinib in xenograft tumors with similar
levels of EGFR expression is robust both as monotherapy and in combination with …

… 3) xenograft models, 3- or 7-day continuous infusions of YM155 (1–10 mg/kg) demonstrated
significant antitumor activity … The broad and potent antitumor activity presented in the present …

… Purpose: We investigated the antitumor activity of the combination of two different …
Experimental Design: Tumor mouse xenograft models were used to examine antitumor activity. Cell …

… (8,13,14), and their antitumor efficacy relative to nontargeted liposomes has not been …
antitumor activity of fL-DOX is compared to that of L-DOX in an FR(+) murine xenograft tumor model…